{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:17:11Z","timestamp":1787847431922,"version":"build-2784847793"},"reference-count":65,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R21CA165039-01A1"],"award-info":[{"award-number":["1R21CA165039-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01CA181183-01A1"],"award-info":[{"award-number":["1R01CA181183-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002608","name":"American Thyroid Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002792","name":"Canadian Association of Optometrists","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002792","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.canlet.2015.07.012","type":"journal-article","created":{"date-parts":[[2015,7,17]],"date-time":"2015-07-17T19:43:55Z","timestamp":1437162235000},"page":"577-585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Expression of angiogenic switch, cachexia and inflammation factors at the crossroad in undifferentiated thyroid carcinoma with BRAF"],"prefix":"10.1016","volume":"380","author":[{"given":"Amjad","family":"Husain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Sadow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelo","family":"Nucera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2015.07.012_bib0010","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.clon.2010.03.013","article-title":"Anaplastic thyroid carcinoma: pathogenesis and emerging therapies","volume":"22","author":"Smallridge","year":"2010","journal-title":"Clin. Oncol. (R. Coll. Radiol.)"},{"key":"10.1016\/j.canlet.2015.07.012_bib0015","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1309\/KXQA3AA9NDBUJDB3","article-title":"Hyalinizing trabecular tumor of the thyroid gland: much ado about nothing?","volume":"122","author":"Boerner","year":"2004","journal-title":"Am. J. Clin. Pathol"},{"key":"10.1016\/j.canlet.2015.07.012_bib0020","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/BF00311551","article-title":"Are cytokines possible mediators of cancer cachexia?","volume":"26","author":"Noguchi","year":"1996","journal-title":"Surg. Today"},{"key":"10.1016\/j.canlet.2015.07.012_bib0025","doi-asserted-by":"crossref","first-page":"563","DOI":"10.4158\/EP09106.CRR","article-title":"Anaplastic thyroid cancer manifesting as new-onset Horner syndrome","volume":"15","author":"Broome","year":"2009","journal-title":"Endocr. Pract"},{"key":"10.1016\/j.canlet.2015.07.012_bib0030","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1158\/1078-0432.CCR-08-3155","article-title":"FOXA1 is a potential oncogene in anaplastic thyroid carcinoma","volume":"15","author":"Nucera","year":"2009","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.canlet.2015.07.012_bib0035","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1210\/jc.2002-021863","article-title":"Clinical review 158: beyond radioiodine: a review of potential new therapeutic approaches for thyroid cancer","volume":"88","author":"Braga-Basaria","year":"2003","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.canlet.2015.07.012_bib0040","doi-asserted-by":"crossref","first-page":"4708","DOI":"10.1200\/JCO.2007.15.9566","article-title":"Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II study","volume":"26","author":"Cohen","year":"2008","journal-title":"J. Clin. Oncol"},{"key":"10.1016\/j.canlet.2015.07.012_bib0045","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1200\/JCO.2008.18.2717","article-title":"Phase II trial of sorafenib in metastatic thyroid cancer","volume":"27","author":"Kloos","year":"2009","journal-title":"J. Clin. Oncol"},{"key":"10.1016\/j.canlet.2015.07.012_bib0050","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1210\/en.2011-1519","article-title":"Late intervention with anti-BRAF(V600E) therapy induces tumor regression in an orthotopic mouse model of human anaplastic thyroid cancer","volume":"153","author":"Nehs","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.canlet.2015.07.012_bib0055","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1210\/er.2012-1038","article-title":"Evolving approaches to patients with advanced differentiated thyroid cancer","volume":"34","author":"Haugen","year":"2013","journal-title":"Endocr. Rev"},{"key":"10.1016\/j.canlet.2015.07.012_bib0060","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","article-title":"Integrated genomic characterization of papillary thyroid carcinoma","volume":"159","author":"Network","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2015.07.012_bib0065","doi-asserted-by":"crossref","first-page":"10649","DOI":"10.1073\/pnas.1004934107","article-title":"B-Raf(V600E) and thrombospondin-1 promote thyroid cancer progression","volume":"107","author":"Nucera","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.canlet.2015.07.012_bib0070","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1073\/pnas.1015557108","article-title":"Thyrotrophin receptor signaling dependence of Braf-induced thyroid tumor initiation in mice","volume":"108","author":"Franco","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.canlet.2015.07.012_bib0075","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1158\/0008-5472.CAN-09-0727","article-title":"Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1","volume":"69","author":"Ricarte-Filho","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2015.07.012_bib0080","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s12253-014-9876-5","article-title":"Anaplastic thyroid cancer: outcome and the mutation\/expression profiles of potential targets","volume":"21","author":"Wu","year":"2015","journal-title":"Pathol. Oncol. Res"},{"key":"10.1016\/j.canlet.2015.07.012_bib0085","doi-asserted-by":"crossref","first-page":"E632","DOI":"10.1210\/jc.2014-3606","article-title":"Association of TERT promoter mutation 1,295,228 C>T with BRAF V600E mutation, older patient age, and distant metastasis in anaplastic thyroid cancer","volume":"100","author":"Shi","year":"2015","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.canlet.2015.07.012_bib0090","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1093\/hmg\/ddu749","article-title":"Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing","volume":"24","author":"Kunstman","year":"2015","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.canlet.2015.07.012_bib0095","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1530\/ERC-12-0031","article-title":"FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinoma","volume":"19","author":"Bellelli","year":"2012","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.canlet.2015.07.012_bib0100","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1210\/jc.2009-2305","article-title":"Approach to the thyroid cancer patient with extracervical metastases","volume":"95","author":"Haugen","year":"2010","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.canlet.2015.07.012_bib0105","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrc3431","article-title":"Molecular pathogenesis and mechanisms of thyroid cancer","volume":"13","author":"Xing","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2015.07.012_bib0110","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/bmj.315.7117.1219","article-title":"ABC of palliative care. Anorexia, cachexia, and nutrition","volume":"315","author":"Bruera","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.canlet.2015.07.012_bib0115","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nrc927","article-title":"Cachexia in cancer patients","volume":"2","author":"Tisdale","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2015.07.012_bib0120","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature13528","article-title":"Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia","volume":"513","author":"Kir","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2015.07.012_bib0125","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/030089168907500223","article-title":"A study of thyroid function in cancer cachexia","volume":"75","author":"Tancini","year":"1989","journal-title":"Tumori"},{"key":"10.1016\/j.canlet.2015.07.012_bib0130","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.jpainsymman.2010.06.021","article-title":"Association between serum cortisol and testosterone levels, opioid therapy, and symptom distress in patients with advanced cancer","volume":"41","author":"Dev","year":"2011","journal-title":"J. Pain Symptom Manage"},{"key":"10.1016\/j.canlet.2015.07.012_bib0135","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.surg.2010.09.001","article-title":"Thyroidectomy with neoadjuvant PLX4720 extends survival and decreases tumor burden in an orthotopic mouse model of anaplastic thyroid cancer","volume":"148","author":"Nehs","year":"2010","journal-title":"Surgery"},{"key":"10.1016\/j.canlet.2015.07.012_bib0140","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1084\/jem.20112446","article-title":"SCF(beta-TRCP) suppresses angiogenesis and thyroid cancer cell migration by promoting ubiquitination and destruction of VEGF receptor 2","volume":"209","author":"Shaik","year":"2012","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.canlet.2015.07.012_bib0145","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1038\/ncomms3824","article-title":"RhoB controls coordination of adult angiogenesis and lymphangiogenesis following injury by regulating VEZF1-mediated transcription","volume":"4","author":"Gerald","year":"2013","journal-title":"Nat. Commun"},{"key":"10.1016\/j.canlet.2015.07.012_bib0150","first-page":"205","article-title":"In vitro matrigel angiogenesis assays","volume":"46","author":"Ponce","year":"2001","journal-title":"Methods Mol. Med"},{"key":"10.1016\/j.canlet.2015.07.012_bib0155","series-title":"World Health Organization Classification of Tumours: Pathology & Genetics: Tumours of Endocrine Organs","author":"DeLellis","year":"2004"},{"key":"10.1016\/j.canlet.2015.07.012_bib0160","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/BF03345351","article-title":"Human galectin-3 immunoexpression in thyroid follicular adenomas with cell atypia","volume":"28","author":"Nucera","year":"2005","journal-title":"J. Endocrinol. Invest"},{"key":"10.1016\/j.canlet.2015.07.012_bib0165","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1111\/j.1582-4934.2009.00947.x","article-title":"Maternal thyroid hormones are transcriptionally active during embryo-foetal development: results from a novel transgenic mouse model","volume":"14","author":"Nucera","year":"2010","journal-title":"J. Cell. Mol. Med"},{"key":"10.1016\/j.canlet.2015.07.012_bib0170","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1089\/thy.2012.0302","article-title":"American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer","volume":"22","author":"Smallridge","year":"2012","journal-title":"Thyroid"},{"key":"10.1016\/j.canlet.2015.07.012_bib0175","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1677\/joe.1.06490","article-title":"Clodronate alleviates cachexia and prolongs survival in nude mice xenografted with an anaplastic thyroid carcinoma cell line","volume":"190","author":"Wang","year":"2006","journal-title":"J. Endocrinol"},{"key":"10.1016\/j.canlet.2015.07.012_bib0180","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canlet.2015.07.012_bib0185","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.cca.2011.12.008","article-title":"Integrative role of neuropeptides and cytokines in cancer anorexia-cachexia syndrome","volume":"413","author":"Patra","year":"2012","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.canlet.2015.07.012_bib0190","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1056\/NEJMoa075853","article-title":"Motesanib diphosphate in progressive differentiated thyroid cancer","volume":"359","author":"Sherman","year":"2008","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.canlet.2015.07.012_bib0195","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1089\/thy.2010.1646","article-title":"Genetic alterations in the phosphatidylinositol-3 kinase\/Akt pathway in thyroid cancer","volume":"20","author":"Xing","year":"2010","journal-title":"Thyroid"},{"key":"10.1016\/j.canlet.2015.07.012_bib0200","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1038\/onc.2013.544","article-title":"Orthotopic mouse models for the preclinical and translational study of targeted therapies against metastatic human thyroid carcinoma with BRAF or wild-type BRAF","volume":"33","author":"Antonello","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2015.07.012_bib0205","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.18632\/oncotarget.2130","article-title":"Combined BRAF(V600E)- and SRC-inhibition induces apoptosis, evokes an immune response and reduces tumor growth in an immunocompetent orthotopic mouse model of anaplastic thyroid cancer","volume":"5","author":"Vanden Borre","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2015.07.012_bib0210","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3389\/fendo.2013.00189","article-title":"Thrombospondin-1 silencing down-regulates integrin expression levels in human anaplastic thyroid cancer cells with BRAF(V600E): new insights in the host tissue adaptation and homeostasis of tumor microenvironment","volume":"4","author":"Duquette","year":"2013","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.canlet.2015.07.012_bib0215","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1634\/theoncologist.2010-0317","article-title":"Targeting BRAFV600E with PLX4720 displays potent antimigratory and anti-invasive activity in preclinical models of human thyroid cancer","volume":"16","author":"Nucera","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.canlet.2015.07.012_bib0220","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10585-012-9500-6","article-title":"Heterogeneity of the tumor vasculature: the need for new tumor blood vessel type-specific targets","volume":"29","author":"Nagy","year":"2012","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.canlet.2015.07.012_bib0225","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10555-011-9315-y","article-title":"EET signaling in cancer","volume":"30","author":"Panigrahy","year":"2011","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.canlet.2015.07.012_bib0230","doi-asserted-by":"crossref","first-page":"168407","DOI":"10.1155\/2014\/168407","article-title":"Inflammation based regulation of cancer cachexia","volume":"2014","author":"Onesti","year":"2014","journal-title":"BioMed Res. Int"},{"key":"10.1016\/j.canlet.2015.07.012_bib0235","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1677\/ERC-08-0036","article-title":"Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer","volume":"15","author":"Ryder","year":"2008","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.canlet.2015.07.012_bib0240","doi-asserted-by":"crossref","first-page":"e22567","DOI":"10.1371\/journal.pone.0022567","article-title":"Tumor-associated macrophages (TAMs) form an interconnected cellular supportive network in anaplastic thyroid carcinoma","volume":"6","author":"Caillou","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2015.07.012_bib0245","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1677\/joe.0.1790387","article-title":"Production of multiple cytokines and induction of cachexia in athymic nude mice by a new anaplastic thyroid carcinoma cell line","volume":"179","author":"Chang","year":"2003","journal-title":"J. Endocrinol"},{"key":"10.1016\/j.canlet.2015.07.012_bib0250","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0002-9610(96)00310-8","article-title":"Patterns of nodal and distant metastasis based on histologic varieties in differentiated carcinoma of the thyroid","volume":"172","author":"Shaha","year":"1996","journal-title":"Am. J. Surg"},{"key":"10.1016\/j.canlet.2015.07.012_bib0255","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1089\/thy.2012.0252","article-title":"Sites of metastases of anaplastic thyroid carcinoma: autopsy findings in 45 cases from a single institution","volume":"23","author":"Besic","year":"2013","journal-title":"Thyroid"},{"key":"10.1016\/j.canlet.2015.07.012_bib0260","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12022-010-9116-9","article-title":"Lymphatic vessel density and VEGF-C expression are significantly different among benign and malignant thyroid lesions","volume":"21","author":"Garcia","year":"2010","journal-title":"Endocr. Pathol"},{"key":"10.1016\/j.canlet.2015.07.012_bib0265","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1084\/jem.20062642","article-title":"Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting","volume":"204","author":"Wirzenius","year":"2007","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.canlet.2015.07.012_bib0270","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1210\/jc.2005-2836","article-title":"Influence of the BRAF V600E mutation on expression of vascular endothelial growth factor in papillary thyroid cancer","volume":"91","author":"Jo","year":"2006","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.canlet.2015.07.012_bib0275","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/S0002-9440(10)65515-0","article-title":"Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features","volume":"155","author":"Bunone","year":"1999","journal-title":"Am. J. Pathol"},{"key":"10.1016\/j.canlet.2015.07.012_bib0280","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/j.humpath.2013.04.014","article-title":"Co-regulatory potential of vascular endothelial growth factor-A and vascular endothelial growth factor-C in thyroid carcinoma","volume":"44","author":"Salajegheh","year":"2013","journal-title":"Hum. Pathol"},{"key":"10.1016\/j.canlet.2015.07.012_bib0285","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1084\/jem.20051848","article-title":"The BRAF-MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells","volume":"203","author":"Sumimoto","year":"2006","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.canlet.2015.07.012_bib0290","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1677\/erc.1.00947","article-title":"RET\/PTC-induced gene expression in thyroid PCCL3 cells reveals early activation of genes involved in regulation of the immune response","volume":"12","author":"Puxeddu","year":"2005","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.canlet.2015.07.012_bib0295","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature14228","article-title":"A gp130-Src-YAP module links inflammation to epithelial regeneration","volume":"519","author":"Taniguchi","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2015.07.012_bib0300","doi-asserted-by":"crossref","first-page":"E2361","DOI":"10.1073\/pnas.1201232109","article-title":"STAT3 negatively regulates thyroid tumorigenesis","volume":"109","author":"Couto","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.canlet.2015.07.012_bib0305","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.smim.2014.01.001","article-title":"IL-6 and related cytokines as the critical lynchpins between inflammation and cancer","volume":"26","author":"Taniguchi","year":"2014","journal-title":"Semin. Immunol"},{"key":"10.1016\/j.canlet.2015.07.012_bib0310","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1158\/2159-8290.CD-12-0531","article-title":"Relief of feedback inhibition of HER3 transcription by RAF and MEK inhibitors attenuates their antitumor effects in BRAF-mutant thyroid carcinomas","volume":"3","author":"Montero-Conde","year":"2013","journal-title":"Cancer Discov"},{"key":"10.1016\/j.canlet.2015.07.012_bib0315","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1479-5876-8-39","article-title":"Differential sensitivity of melanoma cell lines with BRAFV600E mutation to the specific Raf inhibitor PLX4032","volume":"8","author":"Sondergaard","year":"2010","journal-title":"J. Transl. Med"},{"issue":"3","key":"10.1016\/j.canlet.2015.07.012_bib0320","article-title":"Megestrol acetate for treatment of anorexia-cachexia syndrome","author":"Ruiz Garcia","year":"2013","journal-title":"Cochrane Database Syst. Rev"},{"key":"10.1016\/j.canlet.2015.07.012_bib0325","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/hed.2880170109","article-title":"Anaplastic carcinoma of the thyroid: a 24-year experience","volume":"17","author":"Tan","year":"1995","journal-title":"Head Neck"},{"key":"10.1016\/j.canlet.2015.07.012_bib0330","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1210\/jc.2014-2803","article-title":"Personalized therapy in patients with anaplastic thyroid cancer: targeting genetic and epigenetic alterations","volume":"100","author":"Smith","year":"2015","journal-title":"J. Clin. Endocrinol. Metab"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383515004541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383515004541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:40:36Z","timestamp":1759592436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383515004541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0304383515004541"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2015.07.012","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of angiogenic switch, cachexia and inflammation factors at the crossroad in undifferentiated thyroid carcinoma with BRAFV600E","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2015.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}